Islay Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Hold |
35
| – | – | 0.01% | 151 |
|
|
2025
Q1 | $15.2K | Sell |
35
-2,061
| -98% | -$896K | 0.01% | 144 |
|
|
2024
Q4 | $773K | Buy |
2,096
+1,969
| +1,550% | +$726K | 0.54% | 56 |
|
|
2024
Q3 | $66K | Hold |
127
| – | – | 0.04% | 117 |
|
|
2024
Q2 | $68.8K | Hold |
127
| – | – | 0.05% | 116 |
|
|
2024
Q1 | $65.9K | Hold |
127
| – | – | 0.05% | 115 |
|
|
2023
Q4 | $59.9K | Hold |
127
| – | – | 0.05% | 124 |
|
|
2023
Q3 | $55.3K | Hold |
127
| – | – | 0.05% | 123 |
|
|
2023
Q2 | $56.4K | Hold |
127
| – | – | 0.05% | 122 |
|
|
2023
Q1 | $58.4K | Hold |
127
| – | – | 0.06% | 124 |
|
|
2022
Q4 | $65.1K | Hold |
127
| – | – | 0.07% | 114 |
|
|
2022
Q3 | $58K | Sell |
127
-180
| -59% | -$82.2K | 0.07% | 127 |
|
|
2022
Q2 | $148K | Hold |
307
| – | – | 0.15% | 97 |
|
|
2022
Q1 | $151K | Hold |
307
| – | – | 0.13% | 109 |
|
|
2021
Q4 | $142K | Sell |
307
-100
| -25% | -$46.3K | 0.11% | 118 |
|
|
2021
Q3 | $152K | Hold |
407
| – | – | 0.12% | 90 |
|
|
2021
Q2 | $155K | Hold |
407
| – | – | 0.13% | 89 |
|
|
2021
Q1 | $146K | Sell |
407
-140
| -26% | -$50.2K | 0.12% | 98 |
|
|
2020
Q4 | $176K | Hold |
547
| – | – | 0.16% | 75 |
|
|
2020
Q3 | $147K | Buy |
547
+362
| +196% | +$97.3K | 0.15% | 76 |
|
|
2020
Q2 | $49K | Hold |
185
| – | – | 0.06% | 168 |
|
|
2020
Q1 | $42K | Buy |
185
+6
| +3% | +$1.36K | 0.06% | 158 |
|
|
2019
Q4 | $54K | Buy |
+179
| New | +$54K | 0.05% | 163 |
|